Clinical News: Page 2292

MRI: A 'reliable' predictor of giant cell bone tumors
By Wayne Forrest
Monday, November 30 | 10:50 a.m.-11:00 a.m. | SSC11-03 | Room E450BIf you're looking for a reliable predictor of recurrence of giant cell bone tumors, MRI is a much more effective modality than plain radiographs, according to Korean researchers at Seoul National University Hospital.
November 9, 2009
Preoperative MRI can predict clinical outcome after arthroscopic partial meniscectomy
By Wayne Forrest
Monday, November 30 | 10:30 a.m.-10:40 a.m. | SSC10-01 | Room E450APreoperative MRI can be most useful in predicting clinical outcomes after arthroscopic partial meniscectomy in middle-aged and elderly patients, according to researchers from the University of Wisconsin Hospital in Madison.
November 9, 2009
Half-dose gadolinium MR contrast comparable to full dose
By Wayne Forrest
Monday, November 30 | 10:30 a.m.-10:40 a.m. | SSC11-01 | Room E450BAmid concerns about a link between gadolinium-based MR contrast agents and nephrogenic systemic fibrosis in renal-impaired patients, researchers at M. D. Anderson Cancer Center have found that reduced or half-dose contrast enhancement of musculoskeletal lesions may be equivalent to full dose, allowing for cost savings and greater patient safety.
November 9, 2009
Road to RSNA 2009: MRI Preview
By Wayne Forrest
November 9, 2009
Mri
Second CT simulation advised for whole-breast radiation
By Cynthia E. Keen
Women receiving whole-breast radiation therapy after breast-conserving surgery should have two CT simulation exams for treatment planning -- the first prior to treatment planning and the second near the end of treatment prior to delivery of a small-field boost, according to an article in the November issue of the International Journal of Radiation Oncology, Biology, Physics.
November 9, 2009
DensitometrĂ­a Ă³sea revela que la osteoporĂ³sis se combate con cerveza
By Erik L. Ridley
Mientras que el vino ha sido alabado por sus cualidades salubres, la cerveza no ha disfrutado del mismo reconocimiento positivo.
November 8, 2009
Covidien to modify Optimark labeling
By AuntMinnie.com staff writers
Healthcare technology firm Covidien said it will voluntarily contraindicate the use of its Optimark contrast agent in MRI procedures involving patients with severe renal impairment.
November 8, 2009
Delaware orders coverage of VC screening
By AuntMinnie.com staff writers
Beginning December 1, private insurers in the state of Delaware will be required to include virtual colonoscopy as an approved procedure for colorectal cancer screening.
November 8, 2009
Toshiba delivers Aquilion Premium in U.S. hospital
By AuntMinnie.com staff writers
Toshiba America Medical Systems has completed the first installation of its Aquilion Premium CT scanner at a U.S. hospital.
November 8, 2009
Women with dense breasts have higher risk of recurring cancer
By Alexandra Weber Morales
A new study published online today in Cancer has found that breast cancer patients with dense breasts have a four times higher risk of recurring malignancy than women with less-dense breasts. Patients with dense breast tissue might be directed to radiation therapy due to their elevated risk levels, the study suggests.
November 8, 2009
CAD boosts sensitivity of breast MRI
By Erik L. Ridley
Thursday, December 3 | 11:20 a.m.-11:30 a.m. | SSQ01-06 | Arie Crown TheaterComputer-aided detection (CAD) software can improve the sensitivity of breast MRI for both novice and expert readers, according to research from University of Washington Medical Center.
November 8, 2009
Viztek nets New York install
By AuntMinnie.com staff writers
Imaging informatics firm Viztek has announced the installation of its new Opal-CR at the Park Avenue Family Practice in Yonkers, NY.
November 8, 2009
Previous Page
Page 2292 of 3659
Next Page